Fierce Biotech has a listing of the top 15 (potential) late stage blockbusters in development. I think these lists Fierce put out are very interesting. The last one on the list is alpharadin. Its a potential treatment for bone metastases and Bayer just came up with data that it could also be a broad spectrum treatment for prostate cancer. We typically don't discuss late stage development; so few of us have actually been there its like Oz. What makes this so interesting to me is the chemical structure of alpharadin: radium-223 dichloride. RaCl2. Three atoms or 297 g/mol.
I realize this is not a fragment in the true sense of what most of us do. I found it fascinating nonetheless.